NCT04918667 - Effect of Gamma-cyclodextrin on the Bioavailability of Berberine | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2024

Primary Completion Date

November 30, 2025

Study Completion Date

December 31, 2026

Conditions

Drug Absorption

Interventions

COMBINATION_PRODUCT

Berberine incorporated in gamma cyclodextrin

Experimental modified product. One capsule contains 250 mg of Berberine from Indian Barberry (Berberis aristate DC.) Bark and Root Extract incorporated in gamma-cyclodextrin

DIETARY_SUPPLEMENT

Berberine

Active comparator. One capsule contains 500 mg of Berberine from Indian Barberry (Berberis aristate DC.) Bark and Root Extract

Trial Locations (4)

31275

Phytomed AB, Våxtorp

Unknown

CARDIOMED Family Health Center, LLC of the Ministry of Health of the Republic of Armenia, Yerevan

Institute of Fine Organic Chemistry of the National Academy of Science, Yerevan

Scientific Center of Drug and Medical Technologies Expertise, Yerevan

All Listed Sponsors

collaborator

Scientific Center of Drug and Medical Technologies Expertise of the Ministry of Health, Armenia

UNKNOWN

collaborator

Cardiomed LLC, Armenia

UNKNOWN

collaborator

Institute of Fine Organic Chemistry of the National Academy of Science, Armenia

UNKNOWN

collaborator

Phytomed AB, Sweden

UNKNOWN

lead

EuroPharma, Inc.

INDUSTRY